Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 339,980 |
|
|||||
| News | - | ||||||
| Day High | 8.66 | Low High |
|||||
| Day Low | 8.00 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Outlook Therapeutics Inc | OTLK | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 8.20 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 8.29 | 8.00 | 8.66 | 8.17 | 8.20 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,177 | 339,980 | $ 8.27 | $ 2,809,952 | - | 4.004 - 40.60 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:49:29 | 5 | $ 8.48 | USD |
Outlook Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 106.32M | 13.01M | - | 0 | -58.98M | -4.53 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Outlook Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical OTLK Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 8.93 | 9.26 | 7.80 | 8.33 | 257,362 | -0.73 | -8.17% |
| 1 Month | 9.36 | 12.8499 | 7.80 | 9.67 | 547,249 | -1.16 | -12.39% |
| 3 Months | 8.556 | 12.8499 | 5.0401 | 8.46 | 1,481,142 | -0.356 | -4.16% |
| 6 Months | 8.91 | 13.322 | 5.00 | 8.73 | 2,845,006 | -0.71 | -7.97% |
| 1 Year | 23.00 | 40.60 | 4.004 | 10.75 | 4,075,818 | -14.80 | -64.35% |
| 3 Years | 42.60 | 65.40 | 4.004 | 20.20 | 2,135,725 | -34.40 | -80.75% |
| 5 Years | 31.00 | 85.20 | 4.004 | 26.56 | 2,141,144 | -22.80 | -73.55% |
Outlook Therapeutics Description
| Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. |
